.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Argus Health
Moodys
Healthtrust
Julphar
Fuji
Dow
McKinsey
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

DEPAKOTE Drug Profile

« Back to Dashboard

Which patents cover Depakote, and when can generic versions of Depakote launch?

Depakote is a drug marketed by Abbvie and Abbott and is included in four NDAs. There are six patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in DEPAKOTE is divalproex sodium. There are seventeen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbvieDEPAKOTEdivalproex sodiumCAPSULE, DELAYED REL PELLETS;ORAL019680-001Sep 12, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieDEPAKOTE ERdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-002Mar 10, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieDEPAKOTE ERdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
AbbvieDEPAKOTE ERdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
AbbvieDEPAKOTE ERdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
AbbvieDEPAKOTE ERdivalproex sodiumTABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 1984ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-001Mar 10, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbottDEPAKOTE CPdivalproex sodiumTABLET, DELAYED RELEASE;ORAL019794-002Jul 11, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DEPAKOTE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-002Mar 10, 1983► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumCAPSULE, DELAYED REL PELLETS;ORAL019680-001Sep 12, 1989► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-002Mar 10, 1983► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-001Mar 10, 1983► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 1984► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-001Mar 10, 1983► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumTABLET, DELAYED RELEASE;ORAL018723-003Oct 26, 1984► Subscribe► Subscribe
AbbvieDEPAKOTEdivalproex sodiumCAPSULE, DELAYED REL PELLETS;ORAL019680-001Sep 12, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for DEPAKOTE

Drugname Dosage Strength RLD Submissiondate
divalproex sodiumExtended-release Tablets500 mgDepakote ER2/8/2005
divalproex sodiumExtended-release Tablets250 mgDepakote ER5/3/2004

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Julphar
Colorcon
QuintilesIMS
Harvard Business School
Federal Trade Commission
Fuji
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot